Advertisement
BJC Register
For UK healthcare professionals only
  • Current Issue
  • Articles
    • Clinical articles
    • Editorials
    • News and views
  • Archive
  • Supplement archive
  • Learning
    • By programme
    • ACS management
    • Amyloid heart disease
    • Angina
    • Angiography
    • Anticoagulation
    • Anticoagulation reversal
    • Diabetes and CVD
    • Heart failure
    • Heart valve disease
    • Hyperkalaemia
    • Lipids
    • Obesity
    • Pulmonary hypertension
    • Standalone
  • Books
    • CV research 2018 handbook
  • Video
  • Diary
  • Contact
This website is intended for UK healthcare professionals only Log in | Register

BJC supplement 1 2019

Advertisement
Anticoagulation - BJC Learning programme
For healthcare professionals only

Click here to view 'BJC Supplement 1 2019: Advances in the treatment of chronic heart failure with reduced ejection fraction in real-world settings' (8/660)

This is a copyright protected pdf. Each download is for the personal access of one person only. Should you wish to distribute it, then the link https://bjcardio.co.uk/bjc-supplement-1-2019/ should be forwarded to the recipient for download.

Advertisement

Supplements

For healthcare professionals only

Advertisement

Supplements

For healthcare professionals only

Links

    • About
    • Advertisers and media pack
    • Authors’ guidance
    • Editorial staff and board
    • Editorial policy
    • Partners
    • Permissions
    • Subscriptions
facebook page twitter page rss feed

The British Journal of Cardiology Follow

BrJCardiol
brjcardiol The British Journal of Cardiology @brjcardiol ·
21 Jun

Observational study (n= 1702, aged 51–75) shows Inability to stand on one leg for 10 seconds in mid to later life, linked to near doubling in risk of death. https://bjsm.bmj.com/content/early/2022/05/15/bjsports-2021-105360 findings could be applied routinely @GeriSoc @Irishgerontsoc @laramitdr @Roseannekenny1 @tilda_tcd

Reply on Twitter 1539183432256962565 Retweet on Twitter 1539183432256962565 3 Like on Twitter 1539183432256962565 5 Twitter 1539183432256962565
brjcardiol The British Journal of Cardiology @brjcardiol ·
16 Jun

The 2nd CVDPREVENT @HQIP audit to March 2021 shows anticoagulation for high-risk AF and lipid lowering therapy levels for CVD/CKD remain broadly similar in this latest round of data, compared the pre-pandemic baseline.https://www.hqip.org.uk/resource/cvdprevent-second-annual-report/?utm_source=Newsletter&utm_medium=email&utm_content=Just+published%3A+new+national+clinical+reports&utm_campaign=2022-06-16+New+Resource+Notification&vgo_ee=1DpwlTnw1vPRn8VR5oL9XgbtOeHSGxbJq%2B2k9KfQ%2FR8%3D#.YqtY6-zMKYU

Reply on Twitter 1537473860085374976 Retweet on Twitter 1537473860085374976 1 Like on Twitter 1537473860085374976 1 Twitter 1537473860085374976
Load More...

Recent comments

Recommended

Mohamed Aasil Farhan Abdul Lathiff   |   June 23, 2022
On article Anticoagulation module 4: Clinical aspects of anticoagulation

Excellent article

Mohamed Aasil Farhan Abdul Lathiff   |   June 22, 2022
On article Anticoagulation module 3: Anticoagulant therapy

© 2022 Medinews Cardiology Ltd   |   Privacy & cookies policy   |   Terms & conditions Design by Consultants in Design
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now